G(−) Anaerobes–Reactive CD4+ T-Cells Trigger RANKL-Mediated Enhanced Alveolar Bone Loss in Diabetic NOD Mice
- 1 May 2005
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 54 (5) , 1477-1486
Abstract
Diabetic patients experience a higher risk for severe periodontitis; however, the underlying mechanism remains unclear. We investigated the contribution of antibacterial T-cell–mediated immunity to enhanced alveolar bone loss during periodontal infection in nonobese diabetic (NOD) mice by oral inoculation with Actinobacillus actinomycetemcomitans, a G(−) anaerobe responsible for juvenile and severe periodontitis. The results show that 1) inoculation with A. actinomycetemcomitans in pre-diabetic NOD mice does not alter the onset, incidence, and severity of diabetes; 2) after A. actinomycetemcomitans inoculation, diabetic NOD mice (blood glucose >200 mg/dl and with severe insulitis) exhibit significantly higher alveolar bone loss compared with pre-diabetic and nondiabetic NOD mice; and 3) A. actinomycetemcomitans–reactive CD4+ T-cells in diabetic mice exhibit significantly higher proliferation and receptor activator of nuclear factor κB ligand (RANKL) expression. When diabetic mice are treated with the RANKL antagonist osteoprotegerin (OPG), there is a significant reversal of alveolar bone loss, as well as reduced RANKL expression in A. actinomycetemcomitans–reactive CD4+ T-cells. This study clearly describes the impact of autoimmunity to anaerobic infection in an experimental periodontitis model of type 1 diabetes. Thus, microorganism-reactive CD4+ T-cells and the RANKL-OPG axis provide the molecular basis of the advanced periodontal breakdown in diabetes and, therefore, OPG may hold therapeutic potential for treating bone loss in diabetic subjects at high risk.Keywords
This publication has 47 references indexed in Scilit:
- Porphyromonas gingivalisInfection in Pregnant Mice Is Associated with Placental Dissemination, an Increase in the Placental Th1/Th2 Cytokine Ratio, and Fetal Growth RestrictionInfection and Immunity, 2003
- T-cell-receptor gene usage ofActinobacillus actinomycetemcomitans-reactive periodontal CD4+T cells from localized juvenile periodontitis patients and human peripheral blood leukocyte-reconstituted NOD/SCID miceJournal of Periodontal Research, 2002
- Mixed Periodontal Th1-Th2 Cytokine Profile in Actinobacillus actinomycetemcomitans -Specific Osteoprotegerin Ligand (or RANK-L)- Mediated Alveolar Bone Destruction In VivoInfection and Immunity, 2002
- Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic miceJournal of Clinical Investigation, 2000
- Position Paper: Diabetes and Periodontal DiseasesJournal of Periodontology, 2000
- Activated T Lymphocytes Support Osteoclast Formation in VitroBiochemical and Biophysical Research Communications, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- The role of CD4 and CD8 T cells in type I diabetes in the NOD mouseResearch in Immunology, 1997
- Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence.Journal of Experimental Medicine, 1990
- Immunostimulation circumvents diabetes in miceJournal of Autoimmunity, 1989